Preface Part 1: Immune Checkpoint Inhibitors and Autoimmunity

Crit Rev Immunol. 2022;42(3):v-vi. doi: 10.1615/CritRevImmunol.v42.i3.10.

Authors

Vipin Kumar¹, Benjamin Bonavida²

Affiliations

¹ Laboratory of Immune Regulation, Department of Medicine, UCSD School of Medicine, La Jolla, CA 92093, USA.
² Department of Microbiology, Immunology, & Molecular Genetics, David Geffen School of Medicine at UCLA, Johnson Comprehensive Cancer Center, University of California at Los Angeles, Los Angeles, CA 90025-1747, USA.

PMID: 37017621
DOI: 10.1615/CritRevImmunol.v42.i3.10

No abstract available

MeSH terms

Autoimmune Diseases*
Autoimmunity
Humans
Immune Checkpoint Inhibitors / therapeutic use
Neoplasms*

Substances

Immune Checkpoint Inhibitors